|
Lopinavir EP Impurity E
|
洛匹那韋EP雜質(zhì)E
|
192725-49-8
|
|
Iodixanol EP Impurity E
|
碘克沙醇EP雜質(zhì)E
|
255376-57-9
|
|
Ivermectin impurity 8
|
伊維菌素雜質(zhì)8(伊維菌素EP雜質(zhì)G)
|
73162-95-5
|
|
/
|
伊維菌素EP雜質(zhì)I
|
1135339-49-9
|
|
Irinotecan Impurity 6
|
伊立替康雜質(zhì)6
|
143254-82-4
|
|
Irinotecan Impurity 35 (Sodium Salt)
|
伊立替康雜質(zhì)35（鈉鹽）
|
1329502-92-2
|
|
Lasmiditan Impurity 11
|
拉米地坦雜質(zhì)11
|
547724-14-1
|
|
levofloxacin Hydrate
|
左氧氟沙星水合物
|
138199-71-0
|
|
Levetiracetam EP Impurity C
|
左乙拉西坦EP雜質(zhì)C
|
72762-00-6
|
|
Ivermectin EP Impurity C
|
伊維菌素EP雜質(zhì)C
|
65195-57-5
|
|
Lysine impurity 30
|
賴氨酸雜質(zhì)30
|
13795-73-8
|
|
Levetiracetam EP Impurity B
|
左乙拉西坦EP雜質(zhì)B
|
358629-47-7
|
|
Irotinib impurity G
|
依魯替尼雜質(zhì)G
|
936563-97-2
|
|
Iopromide EP Impurity G
|
碘普羅胺EP雜質(zhì)G
|
154361-53-2
|
|
Iodixanol EP Impurity F
|
碘克沙醇EP雜質(zhì)F
|
171897-73-7
|
|
Irotinib impurity E
|
依魯替尼雜質(zhì)E
|
2031255-23-7
|
|
Lobeline hydrochloride impurity intermediate B
|
鹽酸洛貝林雜質(zhì)中間體B
|
614-20-0
|
|
Ivacaftor impurities9
|
依伐卡托雜質(zhì)9
|
83342-70-5
|
|
Lapatinib Impurity 3
|
拉帕替尼雜質(zhì)3
|
320337-10-8
|
|
Lovastatin EP Impurity D
|
洛伐他汀EP雜質(zhì)D
|
149756-62-7
|
|
Lysine impurity 6
|
賴氨酸雜質(zhì)6
|
1946-82-3
|
|
Indoline impurity 14
|
吲哚啉雜質(zhì)14
|
1093086-32-8
|
|
Iodixanol EP Impurity G
|
碘克沙醇EP雜質(zhì)G
|
171897-72-6
|
|
Lapatinib Impurity 4
|
拉帕替尼雜質(zhì)4
|
633370-23-7
|
|
Irotinib impurity F
|
依魯替尼雜質(zhì)F
|
1288338-95-3
|
|
Lobeline hydrochloride impurity starting material B
|
鹽酸洛貝林雜質(zhì)起始物料B(苯甲酰乙酸乙酯)
|
94-02-0
|
|
Lysine impurity 25
|
賴氨酸雜質(zhì)25
|
73-32-5
|
|
Lisinopril Dihydrate
|
二水合賴諾普利
|
83915-83-7
|
|
Indoline impurity 1（Epalrestat impurities）
|
吲哚啉雜質(zhì)1（依帕司他雜質(zhì)）
|
1408072-62-7
|
|
Lansoprazole impurity 48
|
蘭索拉唑雜質(zhì)48
|
166521-76-2
|
|
Irinotecan EP Impurity M
|
伊立替康EP雜質(zhì)M
|
185336-12-3
|
|
Isosorbide nitrate EP impurity C
|
硝酸異山梨酯EP雜質(zhì)C
|
16051-77-7
|
|
Lapatinib Impurity 9
|
拉帕替尼雜質(zhì)9
|
320337-48-2
|
|
Lovastatin EP Impurity F
|
洛伐他汀EP雜質(zhì)F
|
1048973-04-1
|
|
Lansoprazole impurity 50
|
蘭索拉唑雜質(zhì)50
|
102625-96-7
|
|
Lasmiditan Impurity 8
|
拉米地坦雜質(zhì)8
|
33641-61-1
|
|
Levetiracetam EP Impurity A
|
左乙拉西坦EP雜質(zhì)A
|
67118-31-4
|
|
Lisinopril EP Impurity J
|
賴諾普利EP雜質(zhì)J
|
2566937-60-6
|
|
Ilaprazole Impurity 34
|
艾普拉唑雜質(zhì)34
|
86604-77-5
|
|
Lidocaine HCL
|
鹽酸利多卡因-d6(Lidocaine-d6 HCL)
|
73-78-9
|
|
Lurasislone Impurity 19
|
魯拉西酮雜質(zhì)19
|
194861-82-0
|
|
LoratadineEP Impurity H
|
氯雷他定EP雜質(zhì)H
|
29976-53-2
|
|
Iopromide EP Impurity H
|
碘普羅胺EP雜質(zhì)H
|
185459-57-8
|
|
Lisinopril EP Impurity I
|
賴諾普利EP雜質(zhì)I
|
927819-64-5
|
|
Irinotecan Impurity 29
|
伊立替康雜質(zhì)29
|
797762-11-9
|
|
Lidocaine hydrochloride
|
鹽酸利多卡因
|
6108-05-0
|
|
Ivacaftor impurities10
|
依伐卡托雜質(zhì)10
|
26892-90-0
|
|
Ivacaftor impurities2
|
依伐卡托雜質(zhì)2
|
873054-39-8
|
|
Lysine impurity 8
|
賴氨酸雜質(zhì)8
|
657-27-2
|
|
Irinotecan Hydroxy Keto Impurity
|
伊立替康羥酮雜質(zhì)（伊立替康雜質(zhì)1）
|
157770-58-6
|
|
Ivermectin impurity 9
|
伊維菌素雜質(zhì)9(伊維菌素EP雜質(zhì)H)
|
71837-27-9
|
|
Lysine impurity 2
|
賴氨酸雜質(zhì)2
|
94613-75-9
|
|
Lifitegrast Intermediate 4
|
立他司特中間體4
|
1194550-59-8
|
|
Irotinib impurity A
|
依魯替尼雜質(zhì)A
|
1917333-91-5
|
|
Lapatinib Impurity 8
|
拉帕替尼雜質(zhì)8
|
231277-91-1
|
|
Lysine impurity 31
|
賴氨酸雜質(zhì)31
|
4976-72-1
|
|
Irotinib impurity C
|
依魯替尼雜質(zhì)C
|
1288338-96-4
|
|
Irotinib impurity D
|
依魯替尼雜質(zhì)D
|
2417548-76-4
|
|
Irinotecan Impurity 18
|
伊立替康雜質(zhì)18
|
1255644-71-3
|
|
Irinotecan Impurity 21
|
伊立替康雜質(zhì)21
|
870527-52-9
|
|
Ivacaftor impurities8（Kynurenic Acid Impurity 4）
|
依伐卡托雜質(zhì)8（犬尿喹酸雜質(zhì)4）
|
34785-11-0
|
|
Lysine impurity 12
|
賴氨酸雜質(zhì)12
|
13393-44-7
|
|
Kojic Impurity 9
|
曲酸雜質(zhì)9
|
499-78-5
|
|
Lansoprazole impurity 54
|
蘭索拉唑雜質(zhì)54
|
4377-43-9
|
|
Irinotecan Impurity 7
|
伊立替康雜質(zhì)7
|
206182-51-6
|
|
Lactulose impurity 2（Epiregulin）
|
乳果糖雜質(zhì)2（表乳糖）
|
50468-56-9
|
|
Lysine impurity 3
|
賴氨酸雜質(zhì)3
|
58840-79-2
|
|
Irinotecan EP Impurity C
|
伊立替康EP雜質(zhì)C
|
947687-02-7
|
|
Irotinib impurity B
|
依魯替尼雜質(zhì)B
|
1987905-93-0
|
|
Irinotecan Impurity 15
|
伊立替康雜質(zhì)15
|
116269-53-5
|
|
Lapatinib Impurity 10
|
拉帕替尼雜質(zhì)10
|
1393112-45-2
|
|
Lysine impurity 29
|
賴氨酸雜質(zhì)29
|
14529-23-8
|
|
Irinotecan Impurity 43
|
伊立替康雜質(zhì)43
|
181467-56-1
|
|
/
|
伊維菌素EP雜質(zhì)K
|
74567-01-4
|
|
Lansoprazole impurity 53
|
蘭索拉唑雜質(zhì)53
|
168167-48-4
|
|
Irinotecan Impurity 4
|
伊立替康雜質(zhì)4
|
176515-52-9
|
|
Irinotecan Impurity 9
|
伊立替康雜質(zhì)9
|
124622-81-7
|
|
Lapatinib Impurity 27
|
拉帕替尼雜質(zhì)27
|
1202160-61-9
|
|
Ivabradine hydrochloride
|
鹽酸伊伐布雷定
|
148849-67-6
|
|
Lysine impurity 19
|
賴氨酸雜質(zhì)19
|
1621187-55-0
|
|
Irinotecan Impurity 27
|
伊立替康雜質(zhì)27
|
647852-82-2
|
|
Levofloxacin Hydrochloride
|
鹽酸左氧氟沙星
|
177325-13-2
|
|
Lansoprazole impurity 49
|
蘭索拉唑雜質(zhì)49
|
102625-98-9
|
|
Levetiracetam EP Impurity D
|
左乙拉西坦EP雜質(zhì)D
|
103765-01-1
|
|
Irinotecan Impurity 26
|
伊立替康雜質(zhì)26
|
86639-51-2
|
|
Loratadine Impurity 25
|
氯雷他定雜質(zhì)25
|
107256-32-6
|
|
Irinotecan EP Impurity A
|
伊立替康EP雜質(zhì)A
|
103816-16-6
|
|
Lansoprazole impurity 47
|
蘭索拉唑雜質(zhì)47
|
583-61-9
|
|
Irinotecan Impurity 19
|
伊立替康雜質(zhì)19
|
142706-06-7
|
|
Isosorbide nitrate EP impurity B
|
硝酸異山梨酯EP雜質(zhì)B
|
16106-20-0
|
|
Lapatinib Impurity 26
|
拉帕替尼雜質(zhì)26
|
179246-44-7
|
|
Lifitegrast Impurity 23
|
立他司特雜質(zhì)23
|
2271054-95-4
|
|
Lovastatin EP Impurity E
|
洛伐他汀EP雜質(zhì)E
|
77517-29-4
|
|
Irinotecan Impurity 20
|
伊立替康雜質(zhì)20
|
143490-53-3
|
|
Irinotecan Impurity 28
|
伊立替康雜質(zhì)28
|
142677-15-4
|
|
/
|
伊維菌素EP雜質(zhì)D
|
102190-55-6
|
|
Loxoprofen Impurity 15
|
洛索洛芬雜質(zhì)15
|
1091621-62-3
|
|
Irinotecan Furan Ring Impurity
|
伊立替康呋喃環(huán)雜質(zhì)（伊立替康雜質(zhì)3）
|
143490-54-4
|
|
Indobufen Impurity 3
|
吲哚布芬雜質(zhì)3
|
203313-55-7
|
|
Ivacaftor impurities1
|
依伐卡托雜質(zhì)1
|
873051-52-6
|